Side-by-side comparison of AI visibility scores, market position, and capabilities
Purchase NY payment network (NYSE: MA) at $28.2B 2024 revenue, $500B+ market cap; $9T+ gross dollar volume, Recorded Future $2.65B cybersecurity acquisition, Services >35% revenue competing with Visa.
Mastercard Incorporated is a Purchase, New York-based global payment technology network — publicly traded on the New York Stock Exchange (NYSE: MA) as an S&P 500 Financials component with a market capitalization exceeding $500 billion — operating a four-party payment network connecting approximately 3.4 billion cardholders, 90+ million merchant acceptance locations, and 25,000+ financial institution issuers across 210+ countries and territories through approximately 34,000 employees. In Q1 2025, Mastercard reported revenue of $7.3 billion (+14% year-over-year) and diluted EPS of $3.73 (+13%), continuing a trajectory from full-year 2024 revenue of $28.2 billion. Mastercard's network processes over $9 trillion in gross dollar volume annually across credit, debit, and prepaid products. In September 2024, Mastercard acquired Recorded Future for $2.65 billion — the world's largest threat intelligence company — expanding Mastercard's cybersecurity services beyond payment fraud into enterprise security intelligence. Mastercard reorganized its business in April 2024 into three segments: Core Payments, Commercial & New Payment Flows, and Services (the fastest-growing segment, now exceeding 35% of total revenue).
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.